ClinConnect ClinConnect Logo
Search / Trial NCT06609824

Learn to Dare! Leiden

Launched by LEIDEN UNIVERSITY · Sep 19, 2024

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Prevention Childhood Anxiety Shyness

ClinConnect Summary

The "Learn to Dare! Leiden" trial is focused on helping children aged 8 to 18 who struggle with anxiety and shyness. Research shows that many kids experience these feelings but do not get the help they need. This program aims to provide training that encourages children to face their fears and become more confident in themselves. Participants will learn in a safe environment how to stand up for themselves and handle situations that make them anxious. The main goal is to help children develop their skills and prevent long-term issues related to fear and stress.

To be eligible for the trial, children must meet certain requirements, including specific scores on an anxiety assessment. However, those who are currently receiving treatment for anxiety or related issues, or who have other significant mental health concerns, cannot take part. If a child is accepted into the program, they can expect a supportive experience designed to make them feel more comfortable and capable in social situations. Overall, this trial is an exciting opportunity for children to learn and grow in a way that can positively impact their future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Cut-off scores of the SCARED: for girls 31 and for boys 27.
  • Exclusion Criteria:
  • Currently under treatment for anxiety complaints or under treatment in the mental health care system for other internalizing complaints.
  • Anxiety problems or comorbid problems that require attention or treatment (including a 6 or higher on the severity index (CSR) of the ADIS and a score above the clinical cut-off on the Child Depression Inventory.)
  • Difficulty in understanding the training.

About Leiden University

Leiden University, a prestigious research institution located in the Netherlands, is dedicated to advancing knowledge and innovation in various fields, including medicine and healthcare. With a strong emphasis on interdisciplinary collaboration, the university conducts cutting-edge clinical trials that aim to improve patient outcomes and contribute to the scientific community. Its commitment to ethical research practices and adherence to regulatory standards positions Leiden University as a trusted sponsor in the realm of clinical research, fostering advancements that address critical health challenges and enhance the quality of life.

Locations

Leiden, South Holland, Netherlands

Patients applied

0 patients applied

Trial Officials

Anke M Klein, AS

Principal Investigator

Leiden University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported